Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2021, Vol. 17 ›› Issue (06): 740 -744. doi: 10.3877/cma.j.issn.1673-5250.2021.06.017

Original Article

Vaginal microenvironmental imbalance and persistent infection with high-risk human papillomavirus

Chun Yang1,1, Yueyue Chen2,2,(), Lin Zhou3,3, Dan Zhang4,4   

  • Received:2019-12-08 Revised:2021-08-20 Published:2021-12-01
  • Corresponding author: Yueyue Chen
  • Supported by:
    Research Project of Sichuan Provincial Health and Family Planning Commission(17PJ239)
Objective

To investigate relationship between vaginal microecological imbalance and persistent high-risk human papillomavirus (HR-HPV) infection.

Methods

From January 2014 to December 2015, a total of 240 patients, aged 19-73 years old, diagnosed with HR-HPV infection in Department of Gynecology, Science City Hospital of Sichuan. According to HR-HPV infection statuses, they were divided into study group (n=121, those who with persistent HR-HPV infection) and control group (n=119, those who with negative HR-HPV retest). Independent-samples t test was used to statistically analyze weight, body mass index (BMI), gravidity and parity between two groups. The incidence of bacterial vaginosis (BV), vulvovaginal pseudo vaginosis (VVC), trichomoniasis vaginosis (TV), and aerobic vaginitis (AV) between 2 groups were statistically analyzed by chi-square test. The procedures followed in this study were in accordance with the requirements of the World Medical Association Declaration of Helsinki revised in 2013.

Results

① There were no statistically significant differences in general clinical data such as weight, BMI, gravidity and parity between 2 groups (P>0.05). ②The detection rates of BV and VVC in study group were 43.0% (52/121) and 38.0% (46/121), respectively, which were significantly higher than those 20.2% (24/119) and 15.1% (18/119) in control group, and differences were statistically significant (χ2=14.422, 16.075; P=0.002, <0.001). Besides, the differences were not statistically significant in detection rates of TV, AV between 2 groups (P>0.05).

Conclusions

BV and VVC are closely associated with persistent HR-HPV infection, and improving the vaginal microecological environment may help to reduce the incidence of HR-HPV.

表1 2组患者一般临床资料比较(±s)
表2 2组患者阴道分泌物检测异常情况比较[例数(%)]
[1]
Li T, Liu ZH, Li K, et al. Evaluation of the vaginal microbiome in clinical diagnosis and management of vaginal infectious diseases[J]. Chin Med J (Engl), 2019, 132(9):1100-1103. DOI: 10.1097/CM9.0000000000000211.
[2]
Lu Y, Xu X, Nong XH, et al. Detection of high-risk human papillomavirus DNA in sentinel lymph nodes of patients with cervical cancer[J]. Oncol Lett, 2020, 19(3):2317-2325. DOI: 10.3892/ol.2020.11337.
[3]
Chao X, Sun T, Wang S, et al. Research of the potential biomarkers in vaginal microbiome for persistent high-risk human papillomavirus infection[J]. Ann Transl Med, 2020, 8(4):100. DOI: 10.21037/atm.2019.12.115.
[4]
Weston G, Dombrowski C, Harvey MJ, et al. Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation[J]. BMJ Open, 2020, 10(3):e031303. DOI: 10.1136/bmjopen-2019-031303.
[5]
Vos RA, Pasmans H, Tymchenko L, et al. High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands[J]. Vaccine, 2020, 38(13):2816-2826. DOI: 10.1016/j.vaccine.2020.02.017.
[6]
Castle PE, Varallo JE, Bertram MM, et al. High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana[J]. PLoS One, 2020, 15(2):e0229086. DOI: 10.1371/journal.pone.0229086.
[7]
Pańczyszyn A, Boniewska-Bernacka E, Gīąb G. Telomere length in leukocytes and cervical smears of women with high-risk human papillomavirus (HR HPV) infection[J]. Taiwan J Obstet Gynecol, 2020, 59(1):51-55. DOI: 10.1016/j.tjog.2019.11.007.
[8]
Manley KM, Luker R, Park C. An audit of liquid-based cytology samples reported as high-risk human papillomavirus and borderline nuclear change in endocervical cells[J]. Cytopathology, 2020, 31(2):130-135. DOI: 10.1111/cyt.12803.
[9]
Sangpichai S, Patarapadungkit N, Pientong C, et al. Chlamydia trachomatis infection in high-risk human papillomavirus based on cervical cytology specimen[J]. Asian Pac J Cancer Prev, 2019, 20(12):3843-3847. DOI: 10.31557/APJCP.2019.20.12.3843.
[10]
Zhao S, Zhao XL, Hu SY, et al.Comparison of high-risk human papillomavirus infection rate and genotype distribution between Han and Mongolian women[J]. Chin J Epidemiol, 2019, 40(11):1439-1444. DOI: 10.3760/cma.j.issn.0254-6450.2019.11.018.
[11]
Cao M, Wang Y, Wang D, et al. Increased high-risk human papillomavirus viral load is associated with immunosuppressed microenvironment and predicts a worse long-term survival in cervical cancer patients[J]. Am J Clin Pathol, 2020, 153(4):502-512. DOI: 10.1093/ajcp/aqz186.
[12]
Negi SS, Bhargava A, Singh P, et al. Predominance of high-risk human papillomavirus genotype 16 and 39 in women with premalignant and malignant cervical pathology from Raipur, Chhattisgarh: clinical evaluation of tagging oligonucleotide cleavage and extension mediated genotyping assay[J]. Indian J Med Microbiol, 2019, 37(2):255-262. DOI: 10.4103/ijmm.IJMM_19_162.
[13]
Nikouyan N, Farhadi A, Gorzin AA, et al. A fluorometric hybridization assay for detecting and genotyping high-risk human papillomavirus 16 and 18 in archival tissues of cervical specimens[J]. Braz J Microbiol, 2020, 51(1):161-168. DOI: 10.1007/s42770-019-00137-8.
[14]
Kim J, Jun SY. Analytic performance of PANArray HPV and HPV 9G DNA chip tests for genotyping of high-risk human papillomavirus in cervical ThinPrep PreservCyt samples[J]. PLoS One, 2019, 14(10):e0224483. DOI: 10.1371/journal.pone.0224483.
[15]
Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia[J]. J Natl Cancer Inst Monogr, 2003, (31):14-19. DOI: 10.1093/oxfordjournals.jncimonographs.a003476.
[16]
周芳芳,史娜娜. 妊娠期糖尿病孕妇阴道微生态变化及其对妊娠结局的影响[J/CD]. 中华妇幼临床医学杂志(电子版), 2020, 16(6): 714-719. DOI: 10.3877/cma.j.issn.1673-5250.2020.06.014.
[17]
Surriabre P, Torrico A, Vargas T, et al. Assessment of a new low-cost, PCR-based strategy for high-risk human papillomavirus DNA detection for cervical cancer prevention[J]. BMC Infect Dis, 2019, 19(1):842. DOI: 10.1186/s12879-019-4527-9.
[18]
张碧云,肖小敏,钟兴明,等. 肠道菌群紊乱与女性生殖内分泌疾病相关性研究现状[J/CD]. 中华妇幼临床医学杂志(电子版), 2021, 17(4): 488-491. DOI: 10.3877/cma.j.issn.1673-5250.2021.04.017.
[19]
Siegler E, Reichman Y, Kugelman N, et al. Low-risk human papillomavirus types in cervical intraepithelial neoplasia 2-3 and in invasive cervical cancer patients[J]. J Low Genit Tract Dis, 2019, 23(4):248-252. DOI: 10.1097/LGT.0000000000000486.
[20]
Salambanga C, Zohoncon TM, Traoré I, et al. High prevalence of high-risk human papillomavirus (HPV) infection among sexually active women in Ouagadougou[J]. Med Sante Trop, 2019, 29(3):302-305. DOI: 10.1684/mst.2019.0920.
[21]
Luckett R, Mogowa N, Li HJ, et al. Performance of two-stage cervical cancer screening with primary high-risk human papillomavirus testing in women living with human immunodeficiency virus[J]. Obstet Gynecol, 2019, 134(4):840-849. DOI: 10.1097/AOG.0000000000003496.
[22]
杨少岩,赵卫东. 阴道微环境改变与宫颈癌相关性的研究进展[J]. 深圳中西医结合杂志2017, 27(6):4.
[1] Yanjuan Bao, Xiaohong Yang, Tao Zhang, Sheng Zhao, Li Zhang. Ultrasound diagnosis and clinical analysis of obstructed hemivagina and ipsilateral renal anomaly syndrome[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(09): 859-864.
[2] Yunjie Nong, Xiaogui Huang, Yulan Huang, Hengrong Nong. Clinical value of ultrasound in diagnosis of multiple microbial pulmonary infections[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(09): 872-876.
[3] Shuqin Zhang, Lian Chen. Diagnosis and treatment of postpartum intrauterine retained products of conception[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 493-497.
[4] Xiaofei Li, Hongli Liu, Qiuling Shi, Jing Tian, Li Li, Hongbo Qi, Xin Luo. A prospective randomized controlled study of low intensity focused ultrasound uterine involution treatment for prevention and treatment of postpartum hemorrhage in natural childbirth women[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 534-539.
[5] Jiechun Shi, Ziyu Fan, Yan Xing. Early warning efficiency of different screening methods on cervical adenocarcinoma in situ[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 575-581.
[6] Yuefang Xu, Wang Liu, Miaotian Zeng, Yushu Guo. Clinical efficacy of polymyxin B and polymyxin E in the treatment of surgical multi-drug resistant infections Security analysis[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 700-703.
[7] Mengjie Liang, Huanhuan Zhu, Xingzhou Wang, Hang Jiang, Shichao Ai, Feng Sun, Peng Song, Meng Wang, Song Liu, Xuefeng Xia, Junfeng Du, Shuang Fu, Xiaofeng Lu, Xiaofei Shen, Wenxian Guan. Analysis of prognosis and postoperative complications of gastric cancer patients undergoing conversion therapy with combined immunotherapy[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 619-623.
[8] Qinfang Qu, Fanglian Shu. Influencing factors of stress urinary incontinence in patients with pelvic organ prolapse after pelvic floor reconstruction and construction of nomogram prediction model[J]. Chinese Journal of Endourology(Electronic Edition), 2024, 18(06): 606-612.
[9] Donggen Jiang, Yao Feng. The learning curve and experiences of modified single-port laparoscopic ligation of patent processus vaginalis by single surgeon in primary hospital[J]. Chinese Journal of Endourology(Electronic Edition), 2024, 18(06): 560-565.
[10] Maimaitiyusufu Pierdiwasi, Huiling Li, Aili Aikebaier, Zanlin Li, Zhi Wang, Abudureyimu Kelimu. Clinical analysis of giant and recurrent abdominal wall incisional hernia repair with biological mesh[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(06): 624-628.
[11] Xi Gu, Ziyu Xu, Shu Zhou, Wulou Zhang, Yepeng Zhang, Hao Lin, Zonghang Liu, Zhengling Ji, Lifeng Zheng. Mesh infection after tension-free preperitoneal inguinal hernia repair: A report of 10 cases[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(06): 665-669.
[12] Yu Zang, Sheng Yao, Xinyong Zhu, Shipeng Rong, Zhichao Tian. Clinical effect of low temperature plasma ablation technology in the treatment of mesh infection after abdominal wall hernia surgery[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(06): 687-692.
[13] Chuang Yang, Xue Ma. Analysis of risk factors for postoperative infection of abdominal wall hernia[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(06): 693-696.
[14] of Organ Transplantation of Chinese Medical Association Branch. Chinese practice guidelines for diagnosis and treatment of ischemic-type biliary lesion after liver transplantation[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 739-748.
[15] Lingling Jia, Fei Teng, Jian Chang, Fu Huang, Jianping Liu. Progress in application of cardiopulmonary rehabilitation in various diseases[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(09): 859-862.
Viewed
Full text


Abstract